160
Participants
Start Date
May 8, 2023
Primary Completion Date
October 31, 2025
Study Completion Date
December 31, 2025
sirolimus and oseltamivir
Sirolimus 1 mg daily and oseltamivir 75 mg bid for 5 days, both given orally. Extension of dosing to 10 days for oseltamivir and the study drug is allowed if there is slow recovery, lack of improvement, or deterioration.
Oseltamivir
oral oseltamivir 75 mg bid alone for 5 days. Extension of dosing to 10 days for oseltamivir and the study drug is allowed if there is slow recovery, lack of improvement, or deterioration.
RECRUITING
Prince of Wales Hospital, Hong Kong
Chinese University of Hong Kong
OTHER